Clinical Trials Directory

Trials / Completed

CompletedNCT02291393

The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

The Role of High Density Surface Cardiac Electrographic Mapping in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy :A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
The Leeds Teaching Hospitals NHS Trust · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The diagnosis of Arrhythmogenic right ventricular cardiomyopathy can be difficult. The 80 lead ECG may increase the specificity and sensitivity in diagnosing this potentially life threatening inherited cardiac condition. This pilot would form the basis of a much larger clinical trial to test the utility of this novel diagnostic tool.

Conditions

Interventions

TypeNameDescription
DEVICE80 lead ECG

Timeline

Start date
2012-08-01
Primary completion
2012-10-01
Completion
2012-10-01
First posted
2014-11-14
Last updated
2015-05-19

Source: ClinicalTrials.gov record NCT02291393. Inclusion in this directory is not an endorsement.